DE3341806C2 - - Google Patents

Info

Publication number
DE3341806C2
DE3341806C2 DE3341806A DE3341806A DE3341806C2 DE 3341806 C2 DE3341806 C2 DE 3341806C2 DE 3341806 A DE3341806 A DE 3341806A DE 3341806 A DE3341806 A DE 3341806A DE 3341806 C2 DE3341806 C2 DE 3341806C2
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3341806A
Other versions
DE3341806A1 (de
Inventor
Hartmut Prof. Dr.Med. 6301 Heuchelheim De Glossmann
David R. 6300 Giessen De Ferry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glossmann Hartmut Profdrmed 6301 Heuchelheim De
Original Assignee
Glossmann Hartmut Profdrmed 6301 Heuchelheim De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glossmann Hartmut Profdrmed 6301 Heuchelheim De filed Critical Glossmann Hartmut Profdrmed 6301 Heuchelheim De
Priority to DE19833341806 priority Critical patent/DE3341806A1/de
Priority to FR8417380A priority patent/FR2555175B1/fr
Priority to JP59239607A priority patent/JPS60123470A/ja
Priority to GB08429054A priority patent/GB2150137B/en
Priority to US06/672,681 priority patent/US4784958A/en
Publication of DE3341806A1 publication Critical patent/DE3341806A1/de
Application granted granted Critical
Publication of DE3341806C2 publication Critical patent/DE3341806C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/534—Production of labelled immunochemicals with radioactive label
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Quinoline Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19833341806 1983-11-19 1983-11-19 Radioaktiv mit (pfeil hoch)1(pfeil hoch)(pfeil hoch)2(pfeil hoch)(pfeil hoch)5(pfeil hoch)i-markierte 1,4-dihydropyridinderivate und 1,4-dihydrochinolinderivate, ihre herstellung und ihre verwendung zur auspruefung von arzneimitteln Granted DE3341806A1 (de)

Priority Applications (5)

Application Number Priority Date Filing Date Title
DE19833341806 DE3341806A1 (de) 1983-11-19 1983-11-19 Radioaktiv mit (pfeil hoch)1(pfeil hoch)(pfeil hoch)2(pfeil hoch)(pfeil hoch)5(pfeil hoch)i-markierte 1,4-dihydropyridinderivate und 1,4-dihydrochinolinderivate, ihre herstellung und ihre verwendung zur auspruefung von arzneimitteln
FR8417380A FR2555175B1 (fr) 1983-11-19 1984-11-14 Derives de 1,4-dihydropyridine et derives de 1,4-dihydroquinoleine marques radio-activement par 125i, leur preparation et leur application a l'essai des medicaments
JP59239607A JPS60123470A (ja) 1983-11-19 1984-11-15 沃素―１２５により標識された１，４―ジヒドロピリジン誘導体及び１，４―ジヒドロキノリン誘導体、その製造及びその用途
GB08429054A GB2150137B (en) 1983-11-19 1984-11-16 1,4-dihydropyridine derivatives and 1,4-dihydroquinoline derivatives radioactively labelled with 125i, their preparation, and their use in testing medicaments
US06/672,681 US4784958A (en) 1983-11-19 1984-11-19 1,4-dihydropyridine derivatives and 1,4-dihydroquinoline derivatives radioactively labelled with 125 I, their preparation, and their use in testing medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833341806 DE3341806A1 (de) 1983-11-19 1983-11-19 Radioaktiv mit (pfeil hoch)1(pfeil hoch)(pfeil hoch)2(pfeil hoch)(pfeil hoch)5(pfeil hoch)i-markierte 1,4-dihydropyridinderivate und 1,4-dihydrochinolinderivate, ihre herstellung und ihre verwendung zur auspruefung von arzneimitteln

Publications (2)

Publication Number Publication Date
DE3341806A1 DE3341806A1 (de) 1985-05-30
DE3341806C2 true DE3341806C2 (de) 1987-01-08

Family

ID=6214700

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19833341806 Granted DE3341806A1 (de) 1983-11-19 1983-11-19 Radioaktiv mit (pfeil hoch)1(pfeil hoch)(pfeil hoch)2(pfeil hoch)(pfeil hoch)5(pfeil hoch)i-markierte 1,4-dihydropyridinderivate und 1,4-dihydrochinolinderivate, ihre herstellung und ihre verwendung zur auspruefung von arzneimitteln

Country Status (5)

Country Link
US (1) US4784958A (de)
JP (1) JPS60123470A (de)
DE (1) DE3341806A1 (de)
FR (1) FR2555175B1 (de)
GB (1) GB2150137B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3600593A1 (de) * 1986-01-11 1987-07-16 Bayer Ag (pfeil hoch)3(pfeil hoch)(pfeil hoch)5(pfeil hoch)s markierte 1,4-dihydropyridine, verfahren zur herstellung und ihre verwendung
JPS63162409U (de) * 1987-04-13 1988-10-24
US4954436A (en) * 1987-08-06 1990-09-04 Trustees Of Dartmouth College Dihydropyridine-sensitive calcium channel as a tumor associated marker
JPH0476212U (de) * 1990-11-16 1992-07-03
DE4224901A1 (de) * 1992-07-28 1994-02-03 Peter Dr Junghans Anordnung und Verfahren zur Bestimmung des Nitrosierungspotentials in einem biochemischen Reaktionssystem mittels der stabilisotopen ·1··5·N-Markierungstechnik
US5372813A (en) * 1992-12-22 1994-12-13 The Regents, University Of California Substituted 6-nitroquipazines, methods of preparation, and methods of use
WO1996006829A1 (fr) * 1994-08-29 1996-03-07 Mercian Corporation Derive de 1,4-dihydropyrydine
US20050203119A1 (en) * 2003-09-10 2005-09-15 Mitsunori Ono Dihydropyridine compounds for treating or preventing metabolic disorders
JP4952504B2 (ja) * 2007-10-17 2012-06-13 トヨタ自動車株式会社 減圧弁
CN109020875B (zh) * 2018-08-27 2020-05-22 北京市药品检验所 二氢吡啶类化合物脱氢芳构化方法及在药品检测中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2739922A1 (de) * 1977-09-05 1979-03-08 Max Planck Gesellschaft Penicillansaeurederivate, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
US4784958A (en) 1988-11-15
JPS60123470A (ja) 1985-07-02
DE3341806A1 (de) 1985-05-30
GB8429054D0 (en) 1984-12-27
FR2555175A1 (fr) 1985-05-24
FR2555175B1 (fr) 1987-06-05
JPS6224423B2 (de) 1987-05-28
GB2150137A (en) 1985-06-26
GB2150137B (en) 1987-04-15

Similar Documents

Publication Publication Date Title
FR2551191B1 (de)
DE3341806C2 (de)
AT378328B (de)
GR71267B (de)
GR71233B (de)
GR71367B (de)
GR71414B (de)
AU1299683A (de)
AU1412583A (de)
AU9008182A (de)
BG44569A1 (de)
BG44874A3 (de)
BG44584A1 (de)
BG44566A1 (de)
BG43549A1 (de)
BG45222A1 (de)
BG35481A1 (de)
BG44586A1 (de)
BG44897A1 (de)
BG44587A1 (de)
BG45098A1 (de)
BG45096A1 (de)
BG45339A1 (de)
BG44700A1 (de)
BG44707A3 (de)

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee